Clinical Characteristics and Laboratory Findings in Coronavirus Disease 2019 (COVID-2019) Infected Cancer Patients and Chemotherapeutic Medicines against COVID-19
Journal Title: Iberoamerican Journal of Medicine - Year 2020, Vol 2, Issue 4
Abstract
In December 2019 in Wuhan, China, the World Health Organization (WHO) declares that a severe pandemic of Coronavirus disease 2019 (COVID-19) was emerged and was spread rapidly resulted in dramatic global economic and health implications. The novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is responsible for a severe inflammatory reaction and clinically severe complications, although the majority of the infected individuals had mild symptoms and favorable prognosis after recovery. However, cancer patients are a high-risk group as are already susceptible to COVID-19 infection due to their underlying disease and their immunosuppression. Moreover, cancer patients are at increased risk of developing clinically severe complications in case of COVID-19 infection such as, Intensive Care Unit admission, required mechanical ventilation or even death. Another aggravating factor for oncological patients, during that pandemic crisis is the risk of postponing cancer treatment. The present review presents the clinical characteristics accompanied by the corresponding laboratory findings in COVID-19 infected cancer patients and the possible therapeutic role of some known chemo-therapeutic agents based on the recent observations of the International literature.
Authors and Affiliations
Nikolaos Chrysanthakopoulos
Keywords
Related Articles
- EP ID EP689561
- DOI http://dx.doi.org/10.5281/zenodo.4038819
- Views 144
- Downloads 0
Bagassosis, rare cause of hypersensitivity pneumonitis: A case report
Hypersensitivity pneumonitis (HP), also called extrinsic allergic alveolitis, is a respiratory syndrome involving the lung parenchyma specifically the alveoli, terminal bronchioles and alveolar interstitium. HP is caused...
Antibiotic resistance pattern of bacteria isolated from patients with upper respiratory tract infections; a four-year study in Tripoli city
Introduction: Respiratory tract infections have been known to be a significant health concern for mortality and morbidity since many years. This study was aimed at determining the prevalence of bacterial pathogen causing...
The ongoing battle against COVID-19
After spillover from Wuhan (China) in December, 2019, SARS-CoV-2 related respiratory disease (COVID-19) has rapidly affected all countries. The pandemic has posed a serious threat to world health resources. At present, t...
Rosette cataract
............................
ABO Blood Group is Associated with COVID-19 Susceptibility: a Systematic Review and Meta-Analysis
Introduction: Conflicting evidences exist that ABO blood groups correlate with the susceptibility to COVID-19 and its clinical outcomes. This study aimed to pool available articles that assessed a possible relationship b...